May 16, 2024, 08:09 by

Inceptua Group announces an expansion of an Early Access Program for cefiderocol for eligible patients in Argentina, Chile, Colombia, Guatemala, Mexico, and Panama.

May 16, 2024, 08:09 by

Takara Bio announces the launch of PrimeCap™ T7 RNA Polymerase (low dsRNA), a mutant T7 RNA polymerase suitable for mRNA therapeutic research and development.

May 16, 2024, 08:09 by

Icosagen announces a strategic partnership on selected projects with Lead Discovery Center GmbH (LDC) to discover novel monoclonal antibodies.

May 16, 2024, 08:09 by

Mural Health Named “Most Innovative Start-up” at the 2024 Citeline Awards

May 15, 2024, 08:30 by

Indica Labs announced today that it received FDA clearance for HALO AP Dx, an enterprise digital pathology platform, for primary diagnosis.

May 15, 2024, 08:30 by

Elegen is leveraging their next-generation DNA synthesis and production technology to expand into clinical DNA scaleup and manufacturing, a move supported by this Series B round with new investors Trianomic Capital, GSK, and Aldevron co-founder John Ballantyne as well as existing investors. This expansion into clinical applications comes just a little over a year after launching their first product, ENFINIA DNA. To date the company has rapidly enhanced its platform to speed the upstream discovery phase of genetic medicine development, and in January announced a collaboration and licensing agreement with GSK. Investors are confident that Elegen's cell-free, turnkey synthetic DNA platform will transform the speed and reliability of clinical GMP DNA manufacturing.

May 15, 2024, 08:30 by

LG Electronics has launched “Primefocus Health,” a new venture that aims to leverage innovative technologies and new healthcare therapies to enable providers to deliver a personalized, complete care experience and empower individuals to take control of their health at home. This new provider-focused, patient-centric healthcare platform intends to give patients access to new healthcare therapies made available by innovative technology applications, as well as providers access to patient data and progress information to help ensure that their patients are on the right path to better health. Primefocus Health is the first new venture launched by LG NOVA, LG Electronics’ North America Innovation Center.

May 15, 2024, 08:30 by

Metrodora Institute and PrecisionLife announce the start of recruitment on a cohort of up to 1,000 patients into clinical trials to evaluate new diagnosis and treatment options for ME/CFS, Long Covid, and related disorders.

May 14, 2024, 07:27 by

May 14, 2024, 05:00 by User Not Found

Clinical Research News | Researchers at the University of Michigan (U-M) have developed a urine test for prostate cancer known as MyProstateScore 2.0 (MPS2), now a property of spinoff LynxDx, which they expect to significantly improve upon the performance of existing assays by focusing on clinically significant cancers and capturing more biomarkers in a single test.

May 13, 2024, 08:36 by

May 13, 2024, 08:36 by

Drug discovery specialist Cresset has announced a major milestone in its international growth with the launch of a new Indian HQ in Bangalore.

May 10, 2024, 07:39 by

ECI is thrilled to unveil its strategic rebranding, which combines Enhanced Compliance, Inc. and its Costa Rica-based subsidiary CRx Life Sciences into one entity and signals a critical juncture in the company’s ongoing growth and dedication to innovation in the life sciences industry. This fundamental transformation includes a refreshed brand identity, focusing on a refined brand structure and elevated visual appeal.

May 10, 2024, 07:39 by

Josh brings extensive medical device, investment, and growth management experience to his new role.

May 10, 2024, 07:39 by

May 10, 2024, 05:00 by User Not Found

Clinical Research News | The life science industry is changing. There are growing calls for real-world evidence (RWE) and feedback from patients (PROs). Rare diseases are growing in importance, and there is increasing recognition of equity as an ethical and drug-efficacy necessity.

May 9, 2024, 06:55 by

Dr. Tim Garnett, Former Chief Medical Officer of Eli Lilly, Joins Lindus Health's Advisory Board

May 9, 2024, 05:00 by User Not Found

Clinical Research News | A cancer researcher at Florida International University (FIU) has developed a functional precision medicine (FPM) approach to oncology treatment decision-making that combines genomic profiling with drug sensitivity testing on patient-derived tumor cells. Children with relapsed or refractory cancers are among the initial beneficiaries.

May 8, 2024, 07:46 by

Researchers with Sun Genomics and Arizona State University (ASU) have discovered that probiotic supplementation may improve symptoms in people with autism spectrum disorder. The joint metagenomics study assessed the effects of customized probiotic supplementation on children and adults with autism.

May 8, 2024, 07:46 by